Voyager Therapeutics, Inc.
VYGR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001640266
No open-market purchases or sales by Voyager Therapeutics, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $122.7M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Voyager Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 78
- −23 vs. Q1 2021
- Shares held
- 23.4M
- −3.41M (−12.7%) vs. Q1 2021
- Total value
- $96.8M
- −$28.9M (−23.0%) vs. Q1 2021
- New holders
- 16
- 20 more added
- Sold out
- 39
- 28 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VYGR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $122.7M |
| Q1 2026 | 135 | $129.4M |
| Q4 2025 | 125 | $132.6M |
| Q3 2025 | 117 | $141.1M |
| Q2 2025 | 113 | $103.1M |
| Q1 2025 | 116 | $117.4M |
| Q4 2024 | 133 | $196.2M |
| Q3 2024 | 128 | $205.9M |
| Q2 2024 | 127 | $301.6M |
| Q1 2024 | 132 | $331.1M |
| Q4 2023 | 107 | $227.5M |
| Q3 2023 | 111 | $211.2M |
| Q2 2023 | 106 | $307.7M |
| Q1 2023 | 82 | $183.8M |
| Q4 2022 | 70 | $146.2M |
| Q3 2022 | 69 | $142.9M |
| Q2 2022 | 78 | $142.3M |
| Q1 2022 | 70 | $171.3M |
| Q4 2021 | 59 | $51.3M |
| Q3 2021 | 69 | $58.6M |
| Q2 2021 | 78 | $96.8M |
| Q1 2021 | 101 | $125.7M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Voyager Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Man Group plc | 0 | $0 | 0.00% | −17,200−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −15,062−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −14,094−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −12,116−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −11,129−100.0% | Sold out |
| Lincoln Capital Corp | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −9,500−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −4,627−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,642−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −2,021−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −2,126−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −1,458−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −857−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −631−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Wolf Hill Capital Management, LP | 0 | $0 | 0.00% | −163,200−100.0% | Sold out |